
News from GeneOnline News
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top GeneOnline News News

Nanjing · NanjingNANJING, China, Sept. 12, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the first patient has been successfully dosed in a Phase 1b/II clinical trial (NCT07099430) evaluating Opamtistomig (LBL-024, PD-L1/4-1BB…See the Story
Indication Expansion Accelerates: First Patient Dosed in Melanoma Phase 1b/II Trial of Opamtistomig
44% Center coverage: 16 sources

Emmy Awards · Los AngelesThe Emmy Awards, television's equivalent of the Oscars, will take place this Sunday, and pundits say the race for the highly coveted best drama series prize is too close to call.See the Story
'Severance' vs. 'The Pitt' at television's Emmy Awards
50% Center coverage: 14 sources